Sex Differences in Left Ventricular Electrical Dyssynchrony and Outcomes with Cardiac Resynchronization Therapy by Friedman, Daniel J. et al.
 
  
 
Aalborg Universitet
Sex Differences in Left Ventricular Electrical Dyssynchrony and Outcomes with
Cardiac Resynchronization Therapy
Friedman, Daniel J.; Emerek, Kasper; Sørensen, Peter L.; Zeitler, Emily P.; Goldstein, Sarah
A.; Al-Khatib, Sana M.; Søgaard, Peter; Graff, Claus; Atwater, Brett D.
Published in:
Heart Rhythm O2
DOI (link to publication from Publisher):
10.1016/j.hroo.2020.07.004
Creative Commons License
CC BY-NC-ND 4.0
Publication date:
2020
Document Version
Publisher's PDF, also known as Version of record
Link to publication from Aalborg University
Citation for published version (APA):
Friedman, D. J., Emerek, K., Sørensen, P. L., Zeitler, E. P., Goldstein, S. A., Al-Khatib, S. M., Søgaard, P.,
Graff, C., & Atwater, B. D. (2020). Sex Differences in Left Ventricular Electrical Dyssynchrony and Outcomes
with Cardiac Resynchronization Therapy. Heart Rhythm O2, 1(4), 243-249.
https://doi.org/10.1016/j.hroo.2020.07.004
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us at vbn@aub.aau.dk providing details, and we will remove access to
the work immediately and investigate your claim.
Sex differences in left ventricular electrical
dyssynchrony and outcomes with cardiac
resynchronization therapyDaniel J. Friedman, MD,* Kasper Emerek, MD,† Peter L. Sørensen, MSc,‡
Emily P. Zeitler, MD, MHS,x Sarah A. Goldstein, MD,k
Sana M. Al-Khatib, MD, MHS, FHRS,k Peter Søgaard, MD,†{ Claus Graff, PhD,‡
Brett D. Atwater, MDkFrom the *Section of Cardiac Electrophysiology, Yale School of Medicine, New Haven, Connecticut,
†Department of Clinical Medicine, Aalborg University, Aalborg, Denmark, ‡Department of Health
Science and Technology, Aalborg University, Aalborg, Denmark, xDivision of Cardiology, The Geisel
School of Medicine at Dartmouth, Hanover, New Hampshire, kSection of Cardiac Electrophysiology,
Duke University School of Medicine, Durham, North Carolina, and {Department of Cardiology,
Aalborg University Hospital, Aalborg, Denmark.BACKGROUND Women seem to derive more benefit from cardiac re-
synchronization therapy (CRT) than men, even after accounting for
the higher burden of risk factors for nonresponse often observed in
men.
OBJECTIVE To assess for sex-specific differences in left ventricular
(LV) electrical dyssynchrony as a contributing electrophysiological
explanation for the greater degree of CRT benefit among women.
METHODS We compared the extent of baseline LV electrical dyssyn-
chrony, as measured by the QRS area (QRSA), among men and
women with left bundle branch block (LBBB) undergoing CRT at
Duke University (n 5 492, 35% women) overall and in relation to
baseline QRS characteristics using independent sample t tests and
Pearson correlation coefficients. Cox regression analyses were
used to relate sex, QRSA, and QRS characteristics to the risk of car-
diac transplantation, LV assist device implant, or death.
RESULTS Although the mean QRS duration (QRSd) did not differ by
sex, QRSA was greater for women vs men (113.8 mVs vs 98.2 mVs,
P , .001), owing to differences in the QRSd ,150 ms subgroupAddress reprint requests and correspondence: Dr Daniel J. Friedman,
Section of Cardiac Electrophysiology, Yale School of Medicine, Courier
PO Box 208017, New Haven, CT 06520-8017. E-mail address: daniel.j.
friedman@yale.edu.
2666-5018/© 2020 Heart Rhythm Society. Published by Elsevier Inc. This is an op
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4(92.3 6 28.7 mVs vs 67.6 6 26.2 mVs, P , .001). Among those
with nonstrict LBBB, mean QRSd was similar but QRSA was signifi-
cantly greater among women than men (96.0 6 25.0 mVs vs
63.6 6 26.2 mVs, P , .001). QRSA was similar among men and
women with strict LBBB (P 5 .533). Female sex was associated
with better long-term outcomes in an unadjusted model (hazard ra-
tio 0.623, confidence interval 0.454–0.857, P 5 .004) but sex no
longer predicted outcomes after accounting for differences in QRSA.
CONCLUSIONS Our study suggests that sex-specific differences in
LV dyssynchrony contribute to greater CRT benefit among women.
Standard QRSd and morphology assessments seem to underestimate
the extent of LV electrical dyssynchrony among women with LBBB.
KEYWORDS Cardiac resynchronization therapy; Left bundle branch
block; QRS duration; Sex; Vectorcardiography
(Heart Rhythm O2 2020;1:243–249) © 2020 Heart Rhythm Society.
Published by Elsevier Inc. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Cardiac resynchronization therapy (CRT) is the cornerstone
of treatment for patients with heart failure with reduced ejec-
tion fraction and QRS duration (QRSd) prolongation based
on its ability to reduce heart failure hospitalization and
mortality and improve quality of life among appropriate
candidates.1 Several studies have identified that in clinical
trial2–4 and nontrial settings,5–7 women generally havesuperior outcomes compared with men after CRT
implantation. Although this phenomenon may in part be
explained by a higher prevalence of non-sex-based risk fac-
tors for nonresponse among men (eg, ischemic heart disease,
non–left bundle branch block (LBBB), diabetes, atrial ar-
rhythmias), most studies have identified female sex as an in-
dependent predictor of favorable outcomes.
QRS characteristics are important indicators of CRT
benefit and are required for patient selection. The QRS area
(QRSA) is a robust, validated, noninvasive, vectorcardio-
graphically derivedmeasure of left ventricular (LV) electrical
dyssynchrony that has demonstrated substantial relevance to
CRT candidacy.8–13 Increased QRSA is a stronger predictoren access article
.0/).
https://doi.org/10.1016/j.hroo.2020.07.004
KEY FINDINGS
- Although QRS duration (QRSd) is used to infer left ven-
tricular (LV) electrical dyssynchrony and, thus, cardiac
resynchronization therapy (CRT) candidacy in the rele-
vant guidelines without regard to sex, we found that
QRSd is a less reliable indicator of LV electrical dyssyn-
chrony in women compared with men with left bundle
branch block (particularly with shorter QRSd).
- Although QRSd is a strong independent predictor of
survival free of transplant or LV assist device implanta-
tion in men, it does not seem to have prognostic value
in women; conversely, QRS area (QRSA) predicts out-
comes after CRT among both men and women.
- QRSA reduction with CRT pacing was greater among
women than men, suggesting that the greater LV elec-
trical dyssynchrony identified by QRSA is reversible by
CRT pacing.
244 Heart Rhythm O2, Vol 1, No 4, October 2020of LV activation delay than QRSd or morphology10 and is a
robust predictor of LV reverse remodeling with CRT.12
Increased QRSA has also been associated with improved
likelihood of survival free of heart transplant or LV assist de-
vice (LVAD) after CRT,8,13 independent of QRS
morphology and duration. Our group9 and others11 demon-
strated that an in-treatment decrease in QRSA (ie, CRT-
induced reduction in LV electrical dyssynchrony) is associ-
ated with significantly improved outcomes. QRSd reflects
the time between start of ventricular activation and the
conclusion of ventricular depolarization, regardless of which
ventricle contains the most activation delay. As such, signif-
icant activation delay in the right or left ventricle manifests as
a prolonged QRSd. In contrast, QRSA incorporates informa-
tion regarding directionality, timing, and vector magnitude.
Since vector magnitude is dependent on myocardial
mass,14 QRSA is more specific for identifying how much
ventricular mass is experiencing activation delay than QRSd.
Current guidelines most strongly recommend CRT for
patients with greater QRSd prolongation and LBBB
morphology, without specific regard to sex.1 It is increas-
ingly recognized that there are sex-specific differences in
the relationship between QRS characteristics and outcomes
after CRT, such that women tend to derive benefit from
CRT at shorter QRSd than men.3,7,15 However, the actual
electrophysiologic rationale for these findings remains un-
clear. Owing to a critical need to better understand the rea-
sons for sex-specific differences in CRT response,16 we
performed a retrospective analysis of CRT patients to assess
the relationships between QRS characteristics, noninva-
sively assessed LV electrical dyssynchrony via QRSA,
and outcomes. We hypothesized that the relationship be-
tween electrocardiogram (ECG) characteristics and LV elec-
trical dyssynchrony is fundamentally different among
women compared with men.Methods
Study population
Weperformed a retrospective analysis of patientswho received
a de novo CRT with defibrillator (CRT-D) from April 2006 to
September 2015 at Duke University Hospital owing to an un-
derlying LBBB. Patients were first identified using an institu-
tional dataset prepared for submission to the National
Cardiovascular Data Registry. Patients were required to have
a digital ECG within the 180 days prior to CRT implantation
and survive to discharge. If multiple ECGs were available in
the allowable pre-CRT time frame we utilized the ECG closest
to the procedure date. Glomerular filtration rate was calculated
using the Chronic Kidney Disease Epidemiology Collabora-
tion (CKD-EPI) equation.17 The study was approved by the
Duke Institutional Review Board. The Institutional Review
Boardwaived the need for informed consent owing to the retro-
spective nature of the study. This study complied with the
guidelines set forth in the Declaration of Helsinki.ECG analyses
Clinically obtained ECGs were reanalyzed in the GE MUSE
Cardiology Information System version 8.0.2.10132 with
analysis software version 241 (GE Healthcare, Chicago, IL)
and exported in XML format. The fiducial points used to
measure QRSd were manually over-read by 2 readers
(D.J.F. and K.E.). QRS morphology was designated by the
same 2 readers, who were blinded to outcomes. LBBB
morphology was further divided into strict and nonstrict
LBBB using the Strauss criteria.18 Notably, the Strauss
criteria incorporate information on both QRSd and character-
istics (eg, notching).
For the current study, vectorcardiographs were derived
from the XML files using customized MATLAB software
(MathWorks, Inc, Natick, MA) using the Kors matrices.19
We calculated the QRSA8,12 using the median complex.
The integral under the depolarization curve was calculated
for each of the 3 planes (x, y, z) and the 3-dimensional
QRSA was calculated as (QRSx2 1 QRSy2 1QRSz2)1/2.12Endpoints
The study endpoint was a composite of incident LVAD, car-
diac transplant, or death. Endpoint occurrence was deter-
mined via a May 24, 2017, query of the Duke Enterprise
Data Unified Content Explorer, which incorporates data
from billing claims, hospital records, and the Social Security
Death Index.20Statistical analyses
Baseline characteristics of the overall study population strat-
ified by sex were described using proportions for categorical
variables and means and standard deviations for continuous
variables. Differences between groups were tested using
the c2 test for categorical variables and independent sample
t tests for continuous variables. Correlations between QRSd
and QRSA were calculated using Pearson correlation
Table 1 Baseline characteristics of women and men with left
bundle branch block undergoing cardiac resynchronization therapy
Characteristic
Women
(n 5 172)
Men
(n 5 320)
P
value
Age, years 64.0 (12.2) 66.2 (11.0) .038
QRS duration, ms 157.0 (18.0) 156.3 (22.9) .726
QRS area, mVs 113.8 (38.3) 98.2 (44.5) ,.001
Ejection fraction, % 23.1 (7.2) 23.7 (6.8) .301
Atrial fibrillation
or flutter, %
16.9 29.1 .003
Diabetes, % 29.7 33.8 .354
Hypertension, % 62.2 76.9 .001
Ischemic heart disease, % 25.0 59.1 ,.001
CABG, % 8.1 35.6 ,.001
Dialysis, % 2.3 3.1 .611
NYHA class, % .481
I 2.3 3.1
II 16.3 17.8
III 77.9 75.6
IV 3.5 3.4
Primary-prevention
ICD indication, %
94.2 87.8 .024
ACE, % 55.8 64.2 .068
ARB,% 25.0 19.0 .120
Amiodarone, % 8.7 18.0 .006
Beta-blocker, % 89.5 90.2 .818
Glomerular filtration rate,
mL/min/1.73 m2
58 (24) 62 (24) .080
Numbers in parentheses indicate standard deviation.
ACE 5 angiotensin-converting enzyme, ARB 5 angiotensin receptor
blocker, CABG 5 coronary artery bypass grafting, ICD 5 implantable
cardioverter-defibrillator, LBBB 5 left bundle branch block, NYHA 5 New
York Heart Association.
Friedman et al Sex, LV Electrical Dyssynchrony, and CRT Outcomes 245coefficients. Differences in the strength of correlation were
assessed by calculation of a zobs. Sex-based differences in
regression lines relating QRSd and QRSA were assessed us-
ing ANCOVA. For analyses where QRSA was handled as a
categorical variable, a threshold value of 95 mVs was used
based on prior work demonstrating this threshold was able to
discriminate long-term outcome among CRT patients.8
The unadjusted long-term association between patient
characteristics and time until transplant, LVAD, or death
was visually depicted using a Kaplan-Meier plot. The unad-
justed and adjusted risks of various patient and ECG charac-
teristics and time until transplant, LVAD, or death were
assessed using Cox proportional hazards models, after confir-
mation that the proportional hazards assumption was not
violated. Adjustment variables included age, atrial fibrillation
or flutter, ischemic heart disease, ejection fraction, diabetes,
NYHA class, and, depending on the analysis, sex and strict
vs nonstrict LBBB. Statistical analysis was performed in
SPSS version 1.0.0.1327 (IBM, Armonk, NY). A P , .05
and a zobs, -1.96 or. 1.96 were considered statistically sig-
nificant.Results
A total of 492 patients with LBBB underwent CRT-D im-
plantation at Duke University between 2006 and 2015 and
35.0% (n 5 172) were women. Table 1 depicts differencesin baseline characteristics by sex. Women, when compared
with men, were slightly older (66.2 vs 64.0 years, P 5
.038) and more likely to have a primary-prevention implant-
able cardioverter-defibrillator indication (94.2% vs 87.8%,
P5 .024). Women were less likely to have atrial arrhythmias
(16.9% vs 29.1%, P 5 .0003), hypertension (62.2% vs
76.9%, P 5 .001), ischemic heart disease (25.0% vs
59.1%, P , .001), and prior coronary artery bypass grafting
(8.1% vs 35.6%, P , .001). Although QRSd was similar in
women and men (157.0 ms vs 156.3 ms, P 5 .726, respec-
tively), QRSA was greater in women (113.8 mVs vs 98.2
mVs, P , .001). Ejection fraction, NYHA class, and cardio-
vascular drug use were similar for both sexes. Glomerular
filtration rates and rates of dialysis dependence were similar
between the 2 groups.Relationships between sex, QRSd, and LV electrical
dyssynchrony
The correlation between QRSd and QRSA was strong among
men (r 5 0.639, P , .001) but modest among women (r 5
0.496,P, .001) (Figure 1a andb, respectively); formal testing
demonstrated that the strength of correlation was significantly
different by sex (zobs 5 2.257). Thus, although QRSd was
associated with LV electrical dyssynchrony (assessed by
QRSA) in both men and women with LBBB, QRSd was a
better predictor of LV electrical dyssynchrony in men.
Compared with men, the regression line depicting the rela-
tionship between QRSd and QRSA for women demonstrated
a less negative y-intercept and a lesser slope (Figure 1). The
differences in the regression lines relating QRSd and QRSA
by sex were significantly different (ANCOVA P , .001).
Based on the regression equations, a QRSA of 95 mVs8
would occur with a QRSd of 154 ms in a man and a QRSd
of 139 ms in a woman. Since this relationship could be due
to differences in prevalence of strict vs nonstrict LBBB by
sex, this analysis was repeated after stratification by strict
vs nonstrict LBBB; the relationship between QRSA, QRSd,
and sex was the same for both subgroups (P 5 .009 for sex
in strict LBBB cohort, P , .001 for sex in nonstrict LBBB
cohort). Among patients with a QRSd of ,150 ms, women
had a significantly greater QRSA compared with men
(92.3 6 28.7 mVs vs 67.6 6 26.2 mVs, P , .001). Among
the cohort of patients with a QRSd of 150 ms, women
had a slightly greater QRSA that was not statistically signif-
icant (125.6 6 37.9 mVs vs 120.6 6 41.8 mVs, P 5 .305).
Taken together, this suggests that QRSd systematically un-
derestimates the extent of LV electrical dyssynchrony in
women compared with men, particularly at shorter QRSd.Relationships between sex, strict vs nonstrict
LBBB, and LV electrical dyssynchrony
The overall population was stratified by strict (n 5 379) vs
nonstrict LBBB (n 5 113). Although women with strict
LBBB had shorter QRSd than men (159.7 6 16.7 ms vs
166.2 6 18.4, P , .001), the mean QRSA was similar
(115.7 6 39.1 mVs for women vs 113.1 6 42.6 mVs for
Figure 1 Scatterplots relating QRS duration (x-axis) and QRS area (y-axis) among men (a) and women (b) with superimposed best-fit lines.
246 Heart Rhythm O2, Vol 1, No 4, October 2020men, P 5 .533). Women and men with nonstrict LBBB had
similar QRSd (132.6 6 9.1 ms vs 133.2 6 13.6 ms, P 5
.866), but women had significantly greater QRSA compared
with men (96.0 6 25.0 mVs vs 63.6 6 26.2 mVs, P, .001).
Women with nonstrict LBBB were significantly more likely
to have a QRSA 95 mVs than men with nonstrict LBBB (P
, .001; Table 2); among those with strict LBBB, there were
no differences by sex (P 5 .894; Table 2).Table 2 Sex-stratified comparison of the proportion of patients
with a QRS area 95 mVs by strict vs nonstrict left bundle branch
block
Sex
QRSA 95
mVs
Strict LBBB Nonstrict LBBB
P valueCount
Column
N % Count
Column
N %
Male No 78 34.8% 84 87.5% ,.001
Yes 146 65.2% 12 12.5%
Female No 55 35.5% 7 41.2% .643
Yes 100 64.5% 10 58.8%
LBBB 5 left bundle branch block; QRSA 5 QRS area.QRSd vs QRSA and outcomes
Over a median follow-up of 1110 days (interquartile range
647–2117 days), a total of 201 patients met the primary
endpoint (166 patients died, 16 underwent cardiac transplan-
tation, and 19 underwent implantation of an LVAD). In the
overall cohort of LBBB patients (n 5 492), increasing
QRSd (hazard ratio [HR] 0.991 per ms, confidence interval
[CI] 0.985–0.998, P 5 .007) and QRSA (HR 0.990 per
mVs, CI 0.986–0.993, P, .001) were associated with a lower
risk of the composite endpoint. In adjusted models including
age, sex, ejection fraction, diabetes, atrial fibrillation or
flutter, and NYHA class, QRSA (HR 0.991 per mVs, CI
0.987–0.996, P , .001) but not QRSd (HR 0.999 per ms,
CI 0.992–1.007, P5 .888) predicted the composite endpoint.
Female sex was associated with improved outcomes in an
unadjusted analysis (HR 0.623, CI 0.454–0.857, P 5 .004)
and an adjusted analysis (HR 0.667, CI 0.481–0.925, P 5
.015) accounting for age, ejection fraction, atrial fibrillation
or flutter, NYHA class, and QRSd. After additionally adjust-
ing for QRSA in an otherwise similar adjusted model, female
sex was no longer associated with outcomes (P 5 .113).
After stratification by sex, QRSd was associated with the
composite endpoint in men (HR 0.990 per ms, CI 0.983–
0.997, P 5 .004) but not women (HR 0.995 per ms, CI
0.981–1.011, P 5 .553; Pinteraction 5 .003). This is graphi-
cally illustrated by Kaplan-Meier plots constructed after
dichotomizing QRSd using a 150 ms partition (Figure 2).
Conversely, QRSA was associated with composite endpoint
in both men (0.990 per mVs, CI 0.986–0.995, P , .001)
and women (HR 0.990 per mVs, CI 0.983–0.998,
P 5 .011; Pinteraction , .001). This is graphically illustrated
by Kaplan-Meier plots constructed after dichotomizingQRSA using a 95 mVs partition (Figure 3). In adjusted
sex-stratified models, QRSA (but not QRSd) predicted the
composite endpoint for women (HR 0.985 per mVs, CI
0.976–0.995, P 5 .004) and men (HR 0.992 per mVs, CI
0.987–0.997, P 5 .004).QRSd in strict vs nonstrict LBBB
Since QRSA is not readily available from current ECG ma-
chine vendors, we tested whether the strict vs nonstrict
LBBB designation could improve prognostication compared
to QRSd. In unadjusted analyses, presence of strict LBBB
was associated with a significantly lower risk of the compos-
ite endpoint (HR 0.612, CI 0.452–0.827, P 5 .001). There
was a significant interaction between sex and strict vs
nonstrict LBBB (Pinteraction 5 .015) and in unadjusted sex-
stratified analyses, strict LBBB was associated with signifi-
cantly lower risk of the composite endpoint among men
(HR 0.692, CI 0.494–0.968, P 5 .031) and trended toward
being associated with a lower risk in women (HR 0.539, CI
0.252–1.151, P 5 .110). In adjusted sex-stratified models,
strict vs nonstrict LBBB was not associated with outcomes
in either sex and QRSd was associated with outcomes in
men but not women (HR 0.989 per ms, CI 0.979–1.00,
P 5 .041). These results show that use of strict vs nonstrict
LBBB does not improve prognostication beyond use of
QRSd, particularly in women.
Figure 2 Kaplan-Meier plots comparing survival free of left ventricular assist device or cardiac transplant among men (a) and women (b) after stratification by
QRS duration with a 150ms partition. The multivariable model was adjusted for age, ejection fraction, atrial fibrillation or flutter, NYHA class, and QRS area (as a
continuous variable).
Friedman et al Sex, LV Electrical Dyssynchrony, and CRT Outcomes 247CRT-induced changes in QRSA by sex
A total of 351 patients (128 female) had paired baseline and
follow-up post-CRT ECGs suitable for QRSA assessment.
Overall, women had a greater reduction in QRSA with
CRT pacing than men (-45.5 6 41.9 mVs vs -31.3 6 42.3
mVs, P 5 .003) and this difference was driven by the sub-
group of patients with a QRSd ,150 ms (-27.6 6 40.6
mVs vs -10.6 6 34.6 mVs, P 5 .019, for women vs men,
respectively).Discussion
This report, which assessed sex-based differences in QRSd,
LV electrical dyssynchrony, and outcomes among patients
with LBBB undergoing CRT-D, has several key findings.
First, although QRSd is used to infer LV electrical dyssyn-
chrony and, thus, CRT candidacy in the relevant guidelines
without regard to sex, we found that QRSd is a less reliable
indicator of LV electrical dyssynchrony in women compared
with men. Specifically, QRSd systematically underestimates
the extent of LV electrical dyssynchrony in women, particu-
larly those with a QRSd,150 ms. Second, although women
and men with strict LBBB have overall similar degrees of LVFigure 3 Kaplan-Meier plots comparing survival free of left ventricular assist dev
QRS area with a 95 mVs partition. Themultivariable model was adjusted for age, ejec
continuous variable).electrical dyssynchrony, women with nonstrict LBBB have
significantly more LV electrical dyssynchrony compared
with men with nonstrict LBBB. Third, although QRSd is a
robust independent predictor of survival free of transplant
or LVAD implantation in men, it does not seem to have prog-
nostic value in women. Fourth, QRSA was a robust predictor
of event-free survival in both men and women. Fifth, the use
of strict vs nonstrict LBBB does not improve prognostication
beyond use of QRSd, particularly in women. Finally, QRSA
reduction with CRT pacing was greater among women than
men, suggesting that the greater LV electrical dyssynchrony
identified by QRSA is reversible by CRT pacing. Taken
together, these results identify a key mechanism underpin-
ning the observation that women seem to derive more benefit
form CRT compared with men and support the notion that
CRT guidelines may eventually need to consider sex-
specific criteria.
We found that adding QRSA to a multivariable model
rendered sex an insignificant predictor of outcomes after
CRT. These findings are consistent with a prior study by
Okafor and colleagues.11 However, our study extended these
findings by creating 2 successive models to demonstrate that
female sex remained a predictor of outcomes in adjustedice or cardiac transplant among men (a) and women (b) after stratification by
tion fraction, atrial fibrillation or flutter, NYHA class, and QRS duration (as a
248 Heart Rhythm O2, Vol 1, No 4, October 2020models until QRSA was entered into the model. Thus,
although the results from our manuscript were concordant
with those from Okafor and colleagues, our sequential
approach to model building allows one to make firmer con-
clusions regarding the relationship between sex, QRSA,
and outcomes after CRT implantation.
There are several potential explanations for why women
have greater LV electrical dyssynchrony relative to men,
particularly at shorter QRSd. The QRS complex in LBBB
typically begins with depolarization of the right ventricle.
The septal LV endocardium is depolarized 40–80 ms after
QRS onset via transseptal conduction and the activation
wavefront concludes at the lateral LV epicardium at the ter-
minal portion of the QRS.21 Women may have faster trans-
septal conduction times than men, and therefore a greater
proportion of the QRSd may be composed of LV activation
time. If so, QRSd would be expected to be shorter in women
than in men, and may systematically underestimate LV acti-
vation time in women. Faster transseptal conduction times
could be due to differences in the location of block within
the left bundle branch in women compared with men22; dif-
ferences in the number and/or location of septal breakthrough
sites; differences in septal myocardial conduction velocity;
differences in septal fiber orientation, fibrosis, or scar-
ring23,24; differences in the presence or distribution of septal
fascicles; or differences in septal myocardial thickness.25 It is
also possible that differences in LV size between men and
women may influence the observed differences in LV electri-
cal dyssynchrony.
Prior studies have demonstrated that among CRT patients
with LBBB, the normalization of QRS for LV size accounts
for the sex-specific differences in echocardiographic
response26 and survival free of LVAD, transplant, or death.27
These studies suggest that women, compared to men, have
more electrical dyssynchrony. Our study extends these
important findings by directly measuring sex-specific differ-
ences in baseline electrical dyssynchrony (defined by QRSA)
and CRT-induced decreases in electrical dyssynchrony
(defined by change in QRSA). Furthermore, these differences
in baseline and in treatment dyssynchrony remained signifi-
cant after accounting for baseline QRS duration, underscor-
ing the challenges associated with using QRS duration as a
measure of electrical dyssynchrony. Mechanisms other than
differences in LV size may account for the differences in
LV electrical dyssynchrony observed between men and
women.
Current CRT guidelines are sex agnostic and use standard
12-lead ECG criteria (QRSd and morphology) to assess the
extent of LV electrical dyssynchrony.1 Among symptomatic
heart failure patients with LVEF 35% and LBBB, CRT is
recommended as a class I indication if QRSd is 150 ms
and a class IIa indication if the QRSd is ,150 ms. Results
from our study are consistent with many prior studies that
have concluded that sex-specific CRT criteria should be
considered. Additionally, our study is the first to report that
(1) women have more LV electrical dyssynchrony compared
with men and (2) QRSd systematically underestimates theextent of LV electrical dyssynchrony in women, particularly
at shorter QRSd. Taken together, these findings support the
need for future prospective studies that could inform adop-
tion of sex-specific CRT guidelines. Finally, if automated
QRSA assessment becomes widely available, it could prove
clinically useful in determining CRT candidacy rather than
QRSd, as the former seems more accurate than the latter at
identifying LV electrical dyssynchrony (regardless of sex).
In the current era, the most important application of mak-
ing an ECG diagnosis of LBBB in heart failure patients is to
determine CRT candidacy.18 The nearly decade-old proposal
by Strauss and colleagues18 to modify the definition of LBBB
to include sex-specific QRSd criteria (130 ms in women,
140 ms in men) and evidence for delayed LV activation
(ie, notching in consecutive leads) was an important step for-
ward. Results from the current study, which demonstrate sig-
nificant LV electrical dyssynchrony in women (but not men)
with nonstrict LBBB, suggest that the current Strauss criteria
may misclassify a significant proportion of “true” LBBB,
especially in women. These observations should prompt
consideration of new LBBB criteria.Limitations
This study has several important limitations, including the
retrospective study design and single-center nature. Although
we were able to characterize sex-specific differences in LV
electrical dyssynchrony, the absence of a control group pre-
vented us from assessing for sex-specific QRSA thresholds
for determining CRT benefit. Although QRSA is a strong
predictor of LV activation delay,10 it also incorporates infor-
mation on the magnitude of the unopposed vectors and
should not be considered a direct measure of LV activation
delay. No direct measure of LV activation delay was avail-
able for this study. Nonfatal endpoints (LVAD and trans-
plant) were obtained from health system billing records and
were not adjudicated based on blinded committee assess-
ment. Mode of death was not available. Although our
adjusted models included numerous clinical characteristics,
we cannot rule out the possibility of residual confounding.
The study was conducted at a quaternary care center and
therefore the results may not be generalizable to other patient
care settings.Conclusions
We identified sex-specific differences in LV electrical
dyssynchrony that seem to contribute to the greater observed
CRT benefit amongwomen. StandardQRSd andmorphology
assessment underestimates the extent of LV electrical dyssyn-
chrony among women with LBBB, particularly in the context
of shorter QRSd. Prospective studies are needed to assess if
sex-specific CRT criteria are warranted.Funding Sources
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